Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
Submitted by
admin
on January 27, 2017 - 9:30am
Source:
Xtalks
News Tags:
AbbVie
clinical trials
anti-tau antibodies
Alzheimer's disease
ABBV-8E12
Headline:
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
Do Not Allow Advertisers to Use My Personal information
